Cannabis Report
Home > Boards > US Listed > Medical - Drugs > Valeant Pharmaceuticals International (VRX)

FWIW, I never use stop-loss orders -- it’s

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
JohnCM Member Profile
Member Level 
Followed By 484
Posts 40,026
Boards Moderated 27
Alias Born 06/01/08
160x600 placeholder
FDA Issues Complete Response Letter For DUOBRII™ (Halobetasol Propionate and Tazarotene) Lotion PR Newswire (Canada) - 6/18/2018 8:00:00 AM
FDA Issues Complete Response Letter For DUOBRII™ (Halobetasol Propionate and Tazarotene) Lotion PR Newswire (US) - 6/18/2018 8:00:00 AM
Bausch + Lomb Launches Soothe® Xtra Protection Preservative Free Lubricant Eye Drops PR Newswire (Canada) - 6/14/2018 8:00:00 AM
Bausch + Lomb Launches Soothe® Xtra Protection Preservative Free Lubricant Eye Drops PR Newswire (US) - 6/14/2018 8:00:00 AM
Bausch + Lomb Introduces Ocuvite® Blue Light Eye Vitamins PR Newswire (US) - 6/12/2018 8:00:00 AM
Bausch + Lomb Introduces Ocuvite® Blue Light Eye Vitamins PR Newswire (Canada) - 6/12/2018 8:00:00 AM
Securities Class Action Filed on Behalf of Persons or Entities That Traded Certain Derivative Securities of Valeant Pharmaceu... Business Wire - 6/8/2018 6:00:00 PM
Specialized Disclosure Report (sd) Edgar (US Regulatory) - 6/8/2018 5:15:11 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/6/2018 5:17:12 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/1/2018 5:07:42 PM
Valeant Announces Closing Of Amended And Restated Credit Agreement Transaction And Senior Notes Offering, As Well As Redempti... PR Newswire (Canada) - 6/1/2018 4:15:00 PM
Valeant Announces Closing Of Amended And Restated Credit Agreement Transaction And Senior Notes Offering, As Well As Redempti... PR Newswire (US) - 6/1/2018 4:15:00 PM
Salix To Highlight New Clinical Data During Digestive Disease Week PR Newswire (Canada) - 5/31/2018 8:30:00 AM
Salix To Highlight New Clinical Data During Digestive Disease Week PR Newswire (US) - 5/31/2018 8:30:00 AM
Ex-Valeant Executive Convicted In Scheme -- WSJ Dow Jones News - 5/23/2018 3:02:00 AM
Former Valeant Executive Found Guilty on Charges Related to Kickback Scheme Dow Jones News - 5/22/2018 1:48:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/17/2018 5:06:09 PM
Valeant Announces Pricing Of Private Offering Of Notes PR Newswire (Canada) - 5/17/2018 5:00:00 PM
Valeant Announces Pricing Of Private Offering Of Notes PR Newswire (US) - 5/17/2018 5:00:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/17/2018 4:45:09 PM
Valeant Announces Launch Of Private Offering Of Notes And Upsize Of Term Loans PR Newswire (Canada) - 5/17/2018 7:15:00 AM
Valeant Announces Launch Of Private Offering Of Notes And Upsize Of Term Loans PR Newswire (US) - 5/17/2018 7:15:00 AM
Valeant to Participate at the 2018 Barclays High Yield Bond and Syndicated Loan Conference PR Newswire (Canada) - 5/15/2018 8:00:00 AM
Valeant to Participate at the 2018 Barclays High Yield Bond and Syndicated Loan Conference PR Newswire (US) - 5/15/2018 8:00:00 AM
VRX Investor Alert: Kyros Law Announces that it is Filing Legal Claims on Behalf of Valeant Pharmaceuticals Intl (NYSE: VRX) ... PR Newswire (US) - 5/15/2018 7:49:00 AM
JohnCM Member Level  Thursday, 11/09/17 03:35:52 PM
Re: JLS post# 3867
Post # of 4542 
Quote:
FWIW, I never use stop-loss orders -- it’s too easy to get stopped out of a perfectly good position. IMO it’s better to sell CCs when one feels like putting in stop-loss orders and let the market decide whether or not to take the shares. At least you get paid to be taken out. And if you don’t want to be taken out, you can always roll the Calls out and up at relatively low cost.



I have reconsidered. I can use a trailing stop of 15% in case of a catastrophe.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist